Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 33342-196

13 FDA label images from Macleods Pharmaceuticals Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 33342-196). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Venlafaxine 150 140s Carton)

Carton (Venlafaxine 150 140s Carton)
Packaging label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 150 mg, manufactured by Macleods Pharmaceuticals Limited and labeled by Macleods Pharma USA, Inc. The label indicates the product is for oral use and contains 140 capsules (10 x 14 unit doses). The label includes NDC 33342-196-56, storage instructions, and dispensing guidance for pharmacists.*
FDA Label Image

30s-bottle (Venlafaxine 150 30s Bottle)

30s-bottle (Venlafaxine 150 30s Bottle)
Label for Venlafaxine Hydrochloride Extended-Release Capsules USP, 150 mg, manufactured by Macleods Pharmaceuticals Limited. The label states storage instructions, packaging size of 30 capsules, and provides the NDC code 33342-196-07. The label includes a barcode and directions to see the package insert for full prescribing information.*
FDA Label Image

500s-bottle (Venlafaxine 150 500s Bottle)

500s-bottle (Venlafaxine 150 500s Bottle)
Label for Venlafaxine Hydrochloride Extended-Release Capsules USP, 150 mg strength, packaged in a 500-capsule container. The label states storage instructions, dosage guidance to see the package insert, and manufacturer information: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India, distributed by Macleods Pharma USA, Inc., Plainsboro, NJ. The label includes NDC 33342-196-15 and barcodes.*
FDA Label Image

Carton (Venlafaxine 37 5 100s Carton)

Carton (Venlafaxine 37 5 100s Carton)
Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5 mg by Macleods Pharmaceuticals Limited. The label indicates 100 capsules (10 x 10 unit dose) and includes manufacturing details for Macleods Pharma USA, Inc. It instructs pharmacists to dispense the medication guide to each patient and provides storage temperature information.*
FDA Label Image

30s Bottle (Venlafaxine 37 5 30s Bottle)

30s Bottle (Venlafaxine 37 5 30s Bottle)
Label for Venlafaxine Hydrochloride Extended-Release Capsules USP, 37.5 mg strength, oral capsule dosage form. The label shows the product is manufactured by Macleods Pharmaceuticals Limited, Baddi, India, and marketed by Macleods Pharma USA, Inc., Plainsboro, NJ. The package contains 30 capsules. The label includes storage instructions and a barcode.*
FDA Label Image

500s-bottle (Venlafaxine 37 5 500s Bottle)

500s-bottle (Venlafaxine 37 5 500s Bottle)
Venlafaxine hydrochloride Extended-Release Capsules, USP 37.5 mg by Macleods Pharmaceuticals Limited. The label highlights the 37.5 mg strength for oral extended-release capsules. Storage instructions indicate keeping at 20° to 25°C with permitted excursions. The label shows barcodes and notes a quantity of 500 capsules, with manufacturing by Macleods Pharmaceuticals Ltd. in India and Macleods Pharma USA, Inc.*
FDA Label Image

Carton (Venlafaxine 75 140s Carton)

Carton (Venlafaxine 75 140s Carton)
Venlafaxine Hydrochloride Extended-Release Capsules, USP 75 mg, manufactured by Macleods Pharmaceuticals Limited and labeled by Macleods Pharma USA. The label shows a bottle container with a total of 140 extended-release capsules (10 x 14 unit dose). Dosage information includes storage instructions and a note to consult the package insert for full prescribing details. The label also features a barcode and batch/expiration placeholders.*
FDA Label Image

30s-bottle (Venlafaxine 75 30s Bottle)

30s-bottle (Venlafaxine 75 30s Bottle)
Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 75 mg, displaying the extended-release capsule dosage form. The label notes storage instructions and manufacturer details including Macleods Pharma USA and Macleods Pharmaceuticals Ltd. It specifies a quantity of 30 capsules and includes barcode and regulatory information.*
FDA Label Image

500s-bottle (Venlafaxine 75 500s Bottle)

500s-bottle (Venlafaxine 75 500s Bottle)
Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 75 mg, oral extended-release capsule. The label indicates the product is supplied in a package of 500 capsules. It is manufactured by Macleods Pharmaceuticals Ltd. in India and marketed by Macleods Pharma USA, Inc. Storage instructions and dosage directions reference the package insert. The label includes batch and expiration date fields and multiple barcodes.*
FDA Label Image

Fig-1 (Venlafaxine Fig 1)

Fig-1 (Venlafaxine Fig 1)
A pharmacokinetic (PK) fold change chart showing the impact of various interacting drugs on venlafaxine and its metabolite ODV, based on Cmax and AUC values. The graph plots changes relative to a reference value and includes recommendations for dose adjustments or precautions for each interacting drug.*
FDA Label Image

Fig-2 (Venlafaxine Fig 2)

Fig-2 (Venlafaxine Fig 2)
A pharmacokinetic chart showing the fold change and 90% confidence intervals of Cmax and AUC values for various interacting drugs with venlafaxine hydrochloride. The chart includes drugs like ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium, along with clinical recommendations such as dose adjustments or monitoring guidance based on the interactions.*
FDA Label Image

Fig-3 (Venlafaxine Fig 3)

Fig-3 (Venlafaxine Fig 3)
A dot plot chart titled 'Special Population' showing fold changes and 90% confidence intervals in pharmacokinetics parameters (Cmax and AUC) of venlafaxine and its metabolite O-desmethylvenlafaxine (ODV) across various populations including hepatic impairment, renal impairment, CYP2D6 polymorphism, age, and gender. The chart includes dosing recommendations based on these changes, such as dose reductions for certain impairments and no adjustment for others.*
FDA Label Image

Str (Venlafaxine Str)

Str (Venlafaxine Str)
Chemical structure diagram of venlafaxine hydrochloride showing its molecular composition including a methoxyphenyl group, cyclohexanol moiety, and hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.